indazoles has been researched along with Amyotrophic Lateral Sclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeda, K; Iwasaki, Y; Kinoshita, M | 1 |
Beal, MF; Cutting, FB; Dawson, TM; Dawson, VL; Facchinetti, F; Gurney, ME; Huang, PL; MacDonald, JE; Reif, D; Sasaki, M; Zhai, P | 1 |
2 other study(ies) available for indazoles and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Neuronal nitric oxide synthase inhibitor, 7-nitroindazole, delays motor dysfunction and spinal motoneuron degeneration in the wobbler mouse.
Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Hand Strength; Indazoles; Mice; Mice, Neurologic Mutants; Motor Neuron Disease; Motor Neurons; Muscle Denervation; Muscle, Skeletal; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Size; Vacuoles | 1998 |
Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis.
Topics: Amidines; Amyotrophic Lateral Sclerosis; Animals; Catalysis; Enzyme Inhibitors; Indazoles; Isoenzymes; Mice; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Phenotype; Spinal Cord | 1999 |